These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17593991)

  • 61. Comparative assessment of antihypertensive efficacy of DL-nebivolol and D-nebivolol in patients with confirmed mild to moderate hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):619-24. PubMed ID: 7596131
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effects of nebivolol on microcirculation, platelet aggregation and blood viscosity in patients with essential hypertension].
    Zadionchenko VS; Sandomirskaia AP; Adasheva TV; Gorbacheva EV; Matveev DV; Mareeva AP; Buval'tsev VI
    Kardiologiia; 2002; 42(5):14-8. PubMed ID: 12494141
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study.
    Chan TY; Woo KS; Nicholls MG
    Int J Cardiol; 1992 Jun; 35(3):387-95. PubMed ID: 1351888
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
    Heitmann J; Greulich T; Reinke C; Koehler U; Vogelmeier C; Becker HF; Schmidt AC; Canisius S
    Curr Med Res Opin; 2010 Aug; 26(8):1925-32. PubMed ID: 20560730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V
    Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of nebivolol on the state of pituitary-gonadal system and lipid peroxidation in young and middle aged men with hypertension].
    Rakhmatullaeva MD
    Kardiologiia; 2003; 43(2):53-5. PubMed ID: 12891274
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults.
    Werner TJ; Boutagy NE; Osterberg KL; Rivero JM; Davy KP
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):285-92. PubMed ID: 24265181
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X.
    Kayaalti F; Kalay N; Basar E; Mavili E; Duran M; Ozdogru I; Dogan A; Inanc MT; Kaya MG; Topsakal R; Oguzhan A
    Heart Vessels; 2010 Mar; 25(2):92-6. PubMed ID: 20339969
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension.
    Peter P; Martin U; Sharma A; Dunne F
    J Clin Pharm Ther; 2006 Apr; 31(2):153-9. PubMed ID: 16635049
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure.
    Eeftinck Schattenkerk DW; van den Bogaard B; Cammenga M; Westerhof BE; Stroes ES; van den Born BJ
    J Hypertens; 2013 Dec; 31(12):2447-54. PubMed ID: 24126713
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Arterial stiffness, hypertension, and rational use of nebivolol.
    Agabiti-Rosei E; Porteri E; Rizzoni D
    Vasc Health Risk Manag; 2009; 5(1):353-60. PubMed ID: 19475771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Nebivolol effects on the cardiovascular system and the kidneys in pregnant and puerperal women with hypertension].
    Tkacheva ON; Vertkin AL; Barabashkina AV; Vasil'eva AV; Razguliaeva NF
    Ter Arkh; 2006; 78(10):56-61. PubMed ID: 17180940
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
    [No Abstract]   [Full Text] [Related]  

  • 79. The effects of nebivolol on P wave duration and dispersion in patients with coronary slow flow.
    Güneş Y; Tuncer M; Güntekin U; Ceylan Y
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):290-5. PubMed ID: 19666430
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure.
    Stauffer BL; Dow CA; Diehl KJ; Bammert TD; Greiner JJ; DeSouza CA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.